Favorable Stoma-Free Survival in Rectal Cancer Surgery

Coloanal anastomosis offers an impressive 5-year stoma-free survival rate for patients with locally advanced rectal cancer.

5-year stoma-free survival rate is 88.9% at a median follow-up of 53 months.
Factors that worsen survival: BMI ≥ 35 kg/m² (hazard ratio 3.80), handsewn anastomosis with mucosectomy (hazard ratio 5.58), and local recurrence (hazard ratio 6.51).
Major postoperative morbidity rate stands at 7.9%.

Surgeons should consider these factors during patient selection and surgical planning to optimize outcomes.

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Intestine and Lower Gastrointestinal Tract.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

More in Intestine and Lower Gastrointestinal Tract

Ann Surg Oncol2 Nov 2026

Patients smoking at diagnosis were less likely to have a favorable response to treatment before rectal cancer surgery; former smokers were not.

JAMA Surg30 Oct 2026

For severe slow-transit constipation, removing less colon gave similar symptom relief at one year, with less early incontinence.

Surg Endosc29 Oct 2026

In low rectal cancer surgery, removing the specimen through the anus was linked to fewer wound complications and less pain in the first two days.